Wu Capital
Series A
Find your way into Wu Capital
What they invest in
from 5 of 5 portfolio companiesBiotech ×2Crypto & Web3 ×2Enterprise Software ×2Fintech ×2Healthtech ×2AI & Machine Learning ×1Medical Devices ×1SaaS ×1
HQs:Argentina×1China×1Hong Kong×1United States×1
Investments · 5 tracked
founders shown can be your intro pathBy year:2021 · 12020 · 12 dated
Korro Bio is a biotechnology company developing a new class of RNA-editing therapies guided by human genetics and disease biology.
BiotechHealthtechCambridge, US
Nessan Bermingham(Mr. Bermingham is the Executive Chair of the Issuer.)inJean-François Formela(Director)inOmmer Chohan(Mr. Chohan is the Secretary and Treasurer of the Issuer.)inRam Aiyar(Chief Executive Officer, President and Director)inTodd Chappell(Chief Operating Officer)in
BoardJean-Francois Formela(Director)in
Co-investorsAtlas VentureMC Healthcare VenturesNew Enterprise Associates (NEA)AlexandriaQiming Venture Partners USARock Springs Capital+1 more
Laiye offers a Work Execution Platform that lets government and enterprise clients build LLM-driven digital workforces, combining RPA, conversational AI, and intelligent document processing to automate business processes.
AI & Machine LearningEnterprise SoftwareSaaSBeijing, CN
Yichuan Hu(Founder)in
Co-investorsCathay InnovationDCP CapitalLightspeed Venture PartnersSequoia CapitalZhenFundActivant Capital+1 more
Cobo provides a digital asset custody and wallet platform for institutions such as exchanges, funds, and fintechs, offering custodial, MPC, smart contract, and exchange wallets through unified APIs and SDKs.
Crypto & Web3Enterprise SoftwareFintechHong Kong, HK
Changhao Jiang(Founder)in
Co-investorsBitDAOMantle NetworkA&T CapitalDHVCDST GlobalIMO Ventures+1 more
Inipharm is a clinical-stage biopharmaceutical company developing small-molecule inhibitors targeting HSD17B13 to treat severe fibrotic liver diseases, including MASH and other conditions with established genetic validation.
BiotechHealthtechMedical Devices
Brian Farmer(Co-Founder, Chief Executive Officer)inHeather Hsu, PhD(Co-Founder, Chief Scientific Officer)Michael Gallatin, PhD(Co-Founder, SAB Chair)Chuhan Chung(Chief Medical Officer)in
Co-investors5AM VenturesFrazier Life SciencesFrazier Healthcare Partners
Ping is a fintech platform offering free USD accounts and global payment solutions for freelancers and international workers.
Crypto & Web3FintechBuenos Aires, AR
Mary Saracco(Founder)inPablo Orlando(Founder)inJack Saracco(Founder)in
Co-investorsY CombinatorLightspeed China PartnersLightspeed Venture PartnersSequoia Capital
Exits · 1
1 IPOsKorro BioNASDAQ: KRRO
Portfolio news
latest coverage across their companiesCobo · cobo.com · May 28, 2026
Korro Bio · finance.biggo.com · Apr 15, 2026
Frequently asked questions
- How many investments has Wu Capital made?
- Wu Capital has 5 tracked investments, 1 of which have exited.
- What stage does Wu Capital invest at?
- Wu Capital invests at the Series A stage.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
4DI Ventures was co-founded by repeat tech operator and ESET Southern Africa founder Justin Stanford, giving it unusually deep cybersecurity and software operating experience rather than a purely financial background, and originated from Stanford's own angel-investing experiments that directly led to both the firm's creation and the launch of the Silicon Cape Initiative. The firm explicitly describes its style as "nurture capital" with intensive, hands-on engagement, and Stanford is vocal about avoiding the "unicorn at all costs" mentality in African tech, instead emphasizing sustainable market readiness and fundamentals in a more conservative, durability-focused investment approach.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.